Total raised
$2.4M
Last: Undisclosed 2021-08
Stage
Series A
Founded
2017
Headcount
4
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences
About
Serenno Medical is developing a novel method to monitor fluid balance and predict, identify, and avoid common life-threatening complications in intensive care unit (ICU) hospitalizations such as acute kidney injury (AKI). Serenno is using a robust, hands-free, low-cost, and noninvasive device that measures accurate, ongoing urine output. The devices enable contact-free monitoring of hospitalized, quarantined, and home ICU patients. Using the system, medical personnel are alerted to conditions requiring immediate attention, helping to predict and avoid AKI with no need for massive interventions and reducing costs and length of stay.
Funding history · 3 rounds · $2.4M total
2021-08
Undisclosed
Undisclosed
2021-01
Series A
$1.5M
2017-08
Seed
$900K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesMedical Monitors
Technologies
Machinery & Robotics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
remote-monitoringdetectionmedical-deviceshospitalsmeasurementsurinary-systemmonitoringcritical-carehealthcare-providersdata-analyticspatent-pendinghome-caretelehealthdiagnosticsnon-invasivedigital-healthcarepredictive-analytics